Never Run Out Of Buyers To Sell To.
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company leveraging two decades of mechanistic, translational, and clinical research to deliver effective treatments for neurodegenerative diseases affecting millions of families. We are building on breakthroughs in well-established biological pathways underlying neurodegeneration, to lead the charge in developing accessible, novel small-molecule therapies for age-related degenerative diseases that have historically been understudied, underserved, and misunderstood. Zervimesine (CT1812) is Cognition Therapeutics’…
Annual Revenue$10M to $25MBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Estimated OwnershipPublicMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.